A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Amprenavir

DRUG

Nevirapine

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

Trial Locations (12)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

19104

Univ of Pennsylvania at Philadelphia, Philadelphia

29169

Julio Arroyo, West Columbia

30308

Emory Univ, Atlanta

60612

Cook County Hosp, Chicago

63112

St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis

80262

Univ of Colorado Health Sciences Ctr, Denver

275997215

Univ of North Carolina, Chapel Hill

331361013

Univ of Miami School of Medicine, Miami

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

02118

Boston Med Ctr, Boston

02215

Beth Israel Deaconess - West Campus, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001095 - A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir | Biotech Hunter | Biotech Hunter